|
News for Healthier Living
Clinical Trial Shows Newborns with Spinal Muscular Atrophy (SMA) Can Start Treatment at Birth
Results from an international clinical trial found that risdiplam, a drug used to treat the rare neurodegenerative disorder Spinal Muscular Atrophy (SMA), is safe and effective in newborns.
August 13, 2025
August 15 2025August 14 2025August 13 2025August 12 2025August 11 2025August 10 2025August 9 2025August 8 2025August 7 2025August 6 2025August 5 2025August 4 2025August 3 2025August 2 2025
|
|
|
|
|